Package 70771-1626-8

{"route": ["INTRAMUSCULAR"], "spl_id": "6908877d-222b-43e6-a7e9-f264fae84be4", "openfda": {"nui": ["N0000175582", "N0000000145", "N0000000168"], "unii": ["22X328QOC4"], "rxcui": ["727762"], "spl_set_id": ["151b948a-3106-497a-b1c7-479307faeb89"], "pharm_class_epc": ["Estrogen Receptor Antagonist [EPC]"], "pharm_class_moa": ["Estrogen Receptor Antagonists [MoA]", "Selective Estrogen Receptor Modulators [MoA]"], "manufacturer_name": ["Zydus Lifesciences Limited"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "2 SYRINGE, GLASS in 1 CARTON (70771-1626-8)  / 5 mL in 1 SYRINGE, GLASS (70771-1626-2)", "package_ndc": "70771-1626-8", "marketing_start_date": "20211214"}], "brand_name": "FULVESTRANT", "product_id": "70771-1626_6908877d-222b-43e6-a7e9-f264fae84be4", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Estrogen Receptor Antagonist [EPC]", "Estrogen Receptor Antagonists [MoA]", "Selective Estrogen Receptor Modulators [MoA]"], "product_ndc": "70771-1626", "generic_name": "fulvestrant", "labeler_name": "Zydus Lifesciences Limited", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "FULVESTRANT", "active_ingredients": [{"name": "FULVESTRANT", "strength": "50 mg/mL"}], "application_number": "ANDA215234", "marketing_category": "ANDA", "marketing_start_date": "20211214", "listing_expiration_date": "20261231"}